A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Lisdexamfetamine Dimesylate Augmentation for Major Depressive Disorder in Adults With Inadequate Response to Antidepressant Therapy
Journal of Psychopharmacology - United States
doi 10.1177/0269881117722998
Full Text
Open PDFAbstract
Available in full text
Date
August 31, 2017
Authors
Publisher
SAGE Publications